Kristin Stephens - Nov 18, 2024 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Signature
/s/ Todd Rosenthal, as attorney-in-fact
Stock symbol
SYRS
Transactions as of
Nov 18, 2024
Transactions value $
-$7,949
Form type
4
Date filed
11/20/2024, 05:00 PM
Previous filing
Nov 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Sale -$7.95K -36.1K -100% $0.22 0 Nov 18, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.